Showing results (2311-2320 of 2,480) with videos related to
Sort By:
Pageof 248
The Annals of Thoracic Surgery|January 16, 2002
Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesionsA S Aharon, D C Drinkwater, K B Churchwell, et al.Thrombosis and Haemostasis|April 1, 2000
Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia AD H Lee, I R Walker, J Teitel, et al.Diabetologia|July 19, 2008
A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetesD Gong, J Lu, X Chen, et al.The Journal of Organic Chemistry|December 4, 2009
Total synthesis and evaluation of C26-hydroxyepothilone D derivatives for photoaffinity labeling of beta-tubulinEmily A Reiff, Sajiv K Nair, John T Henri, et al.British Journal of Pharmacology|November 17, 2009
Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclaseSyamantak Majumder, Megha Rajaram, Ajit Muley, et al.Neurology. Genetics|January 19, 2017
ABCA7 loss-of-function variants, expression, and neurologic disease riskMariet Allen, Sarah J Lincoln, Morgane Corda, et al.Biorxiv : the Preprint Server for Biology|July 15, 2025
A Transient Increase in Cardiomyocyte Protein O-GlcNAcylation Enhances Susceptibility to Pressure Overload-Induced Cardiac RemodelingSamuel F Chang, Chae-Myeong Ha, Manoja K Brahma, et al.AIDS Research and Human Retroviruses|May 17, 2011
Surveillance of transmitted HIV type 1 drug resistance among HIV type 1-positive women attending an antenatal clinic in Kakinada, IndiaSmita R Thorat, Devidas N Chaturbhuj, Nitin K Hingankar, et al.Transplantation Proceedings|February 5, 2013
Genetic differences in Native Americans and tacrolimus dosing after kidney transplantationH A Chakkera, Y-H Chang, J K Bodner, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 2008
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical studyA A McCormick, S Reddy, S J Reinl, et al.Pageof 248